St. Jude Medical Inc. (STJ)

NYSE - NYSE Real Time Price. Currency in USD
78.01+0.19 (+0.24%)
At close: 4:01 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close77.82
Bid78.60 x 100
Ask78.80 x 500
Day's Range75.34 - 78.18
52wk Range48.83 - 84.00
1y Target EstN/A
Market Cap22.23B
P/E Ratio (ttm)33.92
Avg Vol (3m)2,969,973
Dividend & Yield1.24 (1.51%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Wall Street whipsawed as traders eye Yellen
    Editor's Pick
    Yahoo Financeyesterday

    Wall Street whipsawed as traders eye Yellen

    Stocks whipsawed as Wall Street gets ready for Janet Yellen’s big speech. Catch The Final Round at 4 p.m. ET with Jen Rogers and Joe Fahmy of Zor Capital. Stocks in the red today include Zale’s parent Signet Jewelers as guidance came in way below estimates, discount retailer Dollar General on a profit and revenue miss, even as the retailer upped its share buyback plan, and St. Jude Medical — shares are tumbling after short-seller Muddy Waters issued a report suggesting the company’s medical devices, for example pacemakers, were vulnerable to cyber attack.

  • Short-seller Carson Block is going after one of the most popular hedge fund stocks
    Editor's Pick
    Julia La Roche2 days ago

    Short-seller Carson Block is going after one of the most popular hedge fund stocks

    Short-seller Carson Block, the founder of Muddy Waters Research, just revealed a short position in cardiovascular medical device maker St. Jude Medical (STJ), which is one of the more popular long positions among hedge funds. Muddy Waters sees a “strong possibility” that “close to half” of St. Jude Medical’s revenue could disappear for two years. Specifically, Muddy Waters believes that there should be a recall of the cardio pacemakers.

  • Reuters7 hours ago

    Whiplashed investors stay skittish about St. Jude

    One day after a short seller claimed that St. Jude Medical Inc's heart implants are vulnerable to deadly cyber attacks, investors appear most concerned about whether the accusation will derail St. Jude's $24 billion planned deal for Abbott Labs to buy it. St. Jude's stock at one point fell around 3 percent on Friday, though it ended the day slightly up, following a drop of around 5 percent on Thursday after Muddy Waters Capital leveled the accusation against St. Jude. St. Jude in April agreed to sell itself to Abbott, and the deal was widely considered a slam dunk before the cyber security concerns were raised.